Comparison of 9-month angiographic outcomes of Resolute zotarolimus-eluting and everolimus-eluting stents in a real world setting of coronary intervention in Korea

Table 5 Clinical outcomes during follow-up period in the propensity score matched groups (249 pairs)

	EES	R-ZES	Adjusted HR^*	95% CI	P value
All cause death	4.9 (11)	3.7 (8)	1.833	0.678-4.957	0.232
Cardiac death	2.2 (5)	1.9 (4)	1.667	0.398-6.974	0.484
Any myocardial infarction	2.7 (5)	2.0 (4)	1.000	0.202-4.955	>0.999
Target vessel	2.2 (4)	1.6 (3)	1.500	0.251-8.977	0.657
Target lesion revascularization	5.7 (10)	7.2 (16)	0.533	0.226-1.258	0.151
Target vessel revascularization	7.4 (14)	9.1 (20)	0.706	0.337-1.478	0.356
Any revascularization	22.3 (35)	18.6 (36)	0.833	0.490-1.417	0.501
Target lesion failure	8.4 (16)	8.6 (19)	0.875	0.427-1.793	0.715
Patient-oriented outcome	26.4 (46)	21.1 (42)	1.029	0.642-1.650	0.904

^* Hazard ratio was calculated with stratified Cox proportional hazard regression, values are hazard ratio of EES compared with R-ZES.
Abbreviations: CI confidence interval, EES everolimus-eluting stent, HR hazard ratio, R-ZES Resolute zotarolimus-eluting stent.

ISSN: 1471-2261